Jarad Schiffer

ORCID: 0000-0003-3193-2700
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacillus and Francisella bacterial research
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Outbreaks Research
  • SARS-CoV-2 detection and testing
  • Bacterial Infections and Vaccines
  • Influenza Virus Research Studies
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Pneumonia and Respiratory Infections
  • Viral Infections and Vectors
  • Hepatitis B Virus Studies
  • Respiratory viral infections research
  • Mosquito-borne diseases and control
  • Monoclonal and Polyclonal Antibodies Research
  • Biosensors and Analytical Detection
  • Kawasaki Disease and Coronary Complications
  • Microbial infections and disease research
  • Molecular Biology Techniques and Applications
  • Infective Endocarditis Diagnosis and Management
  • Animal Disease Management and Epidemiology
  • Microbial Inactivation Methods
  • Virology and Viral Diseases
  • Bacterial Genetics and Biotechnology
  • Poxvirus research and outbreaks
  • Congenital Ear and Nasal Anomalies

Centers for Disease Control and Prevention
2015-2024

Office of Readiness and Response
2024

The Centers
2024

National Center for Immunization and Respiratory Diseases
2010-2023

Response Biomedical (Canada)
2020

National Center for Environmental Health
2009

Johns Hopkins Medicine
2006

Johns Hopkins University
2006

University of Bern
1999

University of California, San Diego
1994

A general strategy is described for the de novo design of proteins. In this sequence locations hydrophobic and hydrophilic residues were specified explicitly, but precise identities side chains not constrained varied extensively. This was tested by constructing a large collection synthetic genes whose protein products designed to fold into four-helix bundle Each gene encoded different amino acid sequence, all sequences shared same pattern polar nonpolar residues. Characterization expressed...

10.1126/science.8259512 article EN Science 1993-12-10
Wesley H. Self Mark W. Tenforde William B. Stubblefield Leora R. Feldstein Jay S. Steingrub and 95 more Nathan I. Shapiro Adit A. Ginde Matthew E. Prekker Samuel M. Brown Ithan D. Peltan Michelle N. Gong Michael S. Aboodi Akram Khan Matthew C. Exline D. Clark Files Kevin W. Gibbs Christopher J. Lindsell Todd W. Rice Ian D. Jones Natasha Halasa H. Keipp Talbot Carlos G. Grijalva Jonathan D. Casey David N. Hager Nida Qadir Daniel J. Henning Melissa M. Coughlin Jarad Schiffer Vera Semenova Han Li Natalie J. Thornburg Manish M. Patel Adrienne Baughman Kimberly W. Hart R. Trigg McClellan Rendie McHenry Jakea Johnson Andrea Fletcher Curtis Rich Kemberlyne Cordero Lori Kozikowski Lesley De Souza Sarah Romain Scott Ouellette Andrés Santana Sherell Thornton‐Thompson Michelle Howell Jennifer Peers Shelby K. Shelton Lani Finck Kirsten Soules Michael Klausner Ximena Calderon-Morales Heidi L. Erickson Audrey Hendrickson Jamie Stang Ellen Maruggi Alex Dunn Edward Stenehjem Intermountain Healthcare Valerie Aston Mikaele Bown Michelle M Matheu Rilee Smith Olivia Krol Andrew Salar Oregon Health Makrina Kamel Oregon Health Kelly Nguyen Peter Huynh Sarah Karow Michelle M. Bright Holly Bookless Sandy Mullins Kelly Neidert Dina McGowan Elizabeth Cassandra Emily Brown Claire Carlin Trina A. Wemlinger Breona Edwards Lori Flores Mary LaRose Kathie J. Ferbas Rachel Martin‐Blais Grace M. Aldrovandi Olivia Thompson Sakshi Sehgal Mohammed Ata Ur Rasheed Lisa A. Mills Sandra Lester Brandi Freeman Bailey Alston Muyiwa Ategbole Peter Browning Li Cronin Ebenezer David Rita Desai Monica Epperson

Health care personnel (HCP) caring for patients with coronavirus disease 2019 (COVID-19) might be at high risk contracting SARS-CoV-2, the virus that causes COVID-19. Understanding prevalence of and factors associated SARS-CoV-2 infection among frontline HCP who COVID-19 are important protecting both their patients. During April 3-June 19, 2020, serum specimens were collected from a convenience sample worked 13 geographically diverse academic medical centers in United States, tested...

10.15585/mmwr.mm6935e2 article EN MMWR Morbidity and Mortality Weekly Report 2020-08-31

Compared with the volume of data on coronavirus disease 2019 (COVID-19) outbreaks among older adults, relatively few are available concerning COVID-19 in younger, healthy persons United States (1,2). In late March 2020, aircraft carrier USS Theodore Roosevelt arrived at port Guam after numerous U.S. service members onboard developed COVID-19. April, Navy and CDC investigated this outbreak, demographic, epidemiologic, laboratory findings a convenience sample 382 serving aboard reported study....

10.15585/mmwr.mm6923e4 article EN MMWR Morbidity and Mortality Weekly Report 2020-06-09
Wesley H. Self Mark W. Tenforde William B. Stubblefield Leora R. Feldstein Jay S. Steingrub and 95 more Nathan I. Shapiro Adit A. Ginde Matthew E. Prekker Samuel M. Brown Ithan D. Peltan Michelle N. Gong Michael S. Aboodi Akram Khan Matthew C. Exline D. Clark Files Kevin W. Gibbs Christopher J. Lindsell Todd W. Rice Ian Jones Natasha Halasa H. Keipp Talbot Carlos G. Grijalva Jonathan D. Casey David N. Hager Nida Qadir Daniel J. Henning Melissa M. Coughlin Jarad Schiffer Vera Semenova Han Li Natalie J. Thornburg Manish M. Patel Mohammed Ata Ur Rasheed Lisa A. Mills Sandra Lester Brandi Freeman Bailey Alston Muyiwa Ategbole Peter Browning Shanna Bolcen Darbi Boulay Li Cronin Ebenezer David Rita Desai Monica Epperson Yamini Gorantla Tao Jia Pete Maniatis Kristina Ortiz Sohee Park Palak Patel Yunlong Qin Heather Tatum Briana Zellner Adrienne Baughman Kimberly W. Hart R. Trigg McClellan Rendie McHenry Jakea Johnson Andrea Fletcher Kemberlyne Cordero Lori Kozikowski Lesley De Souza Sarah Romain Scott Ouellette Andrés Santana Sherell Thornton‐Thompson Michelle Howell Jennifer Peers Shelby K. Shelton Lani Finck Kirsten Soules Michael Klausner Ximena Calderon-Morales Heidi L. Erickson Audrey Hendrickson Jamie Stang Ellen Maruggi Alex Dunn Edward Stenehjem Valerie Aston Mikaele Bown Michelle M Matheu Rilee Smith Olivia Krol Andrew Salar Makrina Kamel Kelly Nguyen Peter Huynh Sarah Karow Michelle M. Bright Holly Bookless Sandy Mullins Kelly Neidert Dina McGowan Elizabeth Cassandra Emily Brown Claire Carlin Trina A. Wemlinger Breona Edwards

Most persons infected with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), develop virus-specific antibodies within several weeks, but antibody titers might decline over time. Understanding timeline of is important for interpreting SARS-CoV-2 serology results. Serum specimens were collected from a convenience sample frontline health care personnel at 13 hospitals and tested to during April 3-June 19, 2020, again approximately 60 days later assess this timeline. The...

10.15585/mmwr.mm6947a2 article EN MMWR Morbidity and Mortality Weekly Report 2020-11-25

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes disease 2019 (COVID-19), was first identified in Wuhan, China, December 2019, with subsequent worldwide spread. The US cases were January 2020. Methods To determine if SARS-CoV-2–reactive antibodies present sera prior to case United States on 19 2020, residual archived samples from 7389 routine blood donations collected by American Red Cross 13 17 2020 donors resident 9 states (California,...

10.1093/cid/ciaa1785 article EN public-domain Clinical Infectious Diseases 2020-11-26

These recommendations from the Advisory Committee on Immunization Practices (ACIP) update previous for anthrax vaccine adsorbed (AVA) (CDC. Use of in United States: Recommendations [ACIP]. MMWR 2000;49:1-20; CDC. response to terrorism: supplemental 2002;51:1024-6) and reflect status supplies States. This statement 1) provides updated information epidemiology; 2) summarizes evidence regarding effectiveness efficacy, immunogenicity, safety AVA; 3) pre-event preexposure use 4) postexposure AVA....

10.15585/mmwr.rr6804a1 article EN MMWR Recommendations and Reports 2019-12-12

Abstract Importance Reported cases of SARS-CoV-2 infection likely underestimate the prevalence in affected communities. Large-scale seroprevalence studies provide better estimates proportion population previously infected. Objective To estimate antibodies convenience samples from several geographic sites United States. Design Serologic testing using residual sera obtained for routine clinical by two commercial laboratory companies. Setting Connecticut (CT), south Florida (FL), Missouri (MO),...

10.1101/2020.06.25.20140384 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-06-26

ABSTRACT Swine origin 2009 H1N1 influenza virus has spread globally to cause the first pandemic of 21st century. Serological studies can improve our understanding extent human infection and risk factors associated with transmission this virus. The “gold standard” for serodiagnosis is detection seroconversion between acute- convalescent-stage samples. However, timing seroepidemiological investigations often precludes collection truly acute-phase sera, requiring development serological...

10.1128/jcm.00229-11 article EN Journal of Clinical Microbiology 2011-04-07

.Streptococcus pneumoniae is a highly impactful bacterial pathogen on global scale. The principal pneumococcal virulence factor and target of effective vaccines its polysaccharide capsule, which there are many structurally distinct forms. Here we describe four strains three Mitis group commensal species (Streptococcus infantis, Streptococcus mitis, oralis) recovered from upper respiratory tract specimens adults in Kenya the United States that were PCR-positive for serotype 5 specific gene,...

10.3389/fmicb.2018.03199 article EN cc-by Frontiers in Microbiology 2019-01-08

Lethal toxin–neutralizing activity in serum after vaccination can provide cross-species predictions of survival against inhalation anthrax.

10.1126/scitranslmed.3004073 article EN Science Translational Medicine 2012-09-12

ABSTRACT A 3-dose (0, 1, and 6 months) intramuscular (3-IM) priming series of a human dose (HuAVA) dilutions up to 1:10 anthrax vaccine adsorbed (AVA) provided statistically significant levels protection (60 100%) against inhalation for 4 years in rhesus macaques. Serum anti-protective antigen (anti-PA) IgG lethal toxin neutralization activity (TNA) were detectable following single injection HuAVA or 1:5 AVA two injections diluted (1:10, 1:20, 1:40 AVA). Anti-PA TNA highly correlated...

10.1128/cvi.00324-12 article EN Clinical and Vaccine Immunology 2012-08-29

Because of health concerns surrounding in utero and neonatal exposure to perchlorate, we developed a method for analyzing perchlorate the dried blood spots (DBS) newborns. Ion chromatography was interfaced with electrospray ionization tandem mass spectrometry measure levels DBS samples as low 0.10 ng/mL. Measurement indicated good precision (relative standard deviations ranging from 5.8% 16.2%) accuracy (% difference values -11.3% -12.1%). Perchlorate detectable 100% collected 100 These had...

10.1021/ac802419n article EN Analytical Chemistry 2009-01-27

Natural infection-induced humoral immunity to matrix protein 2 (M2) of influenza A viruses in humans is not fully understood. Evidence suggests that anti-M2 antibody responses following virus infection are weak and/or transient. We show the seroprevalence antibodies increased with age 317 serum samples from healthy individuals United States 2007-2008. Infection 2009 pandemic H1N1 (A[H1N1]pdm09) elicited a recall response M2 A(H1N1)pdm09 47% affected 118 tested. Anti-M2 were more robust among...

10.1093/infdis/jit811 article EN public-domain The Journal of Infectious Diseases 2013-12-10

Cutaneous anthrax outbreaks occurred in Bangladesh from August to October 2009. As part of the epidemiological response and confirm diagnoses, serum samples were collected suspected case patients with observed cutaneous lesions. Anthrax lethal factor (LF), anti-protective antigen (anti-PA) immunoglobulin G (IgG), toxin neutralization activity (TNA) levels determined acute convalescent 26 first largest these outbreaks. LF (0.005–1.264 ng/mL) was detected 18 individuals. Anti-PA IgG TNA sera...

10.1093/infdis/jir543 article EN cc-by-nc The Journal of Infectious Diseases 2011-09-10

ABSTRACT Humoral and cell-mediated immune correlates of protection (COP) for inhalation anthrax in a rhesus macaque ( Macaca mulatta ) model were determined. The immunological survival data from 114 vaccinated 23 control animals exposed to Bacillus anthracis spores at 12, 30, or 52 months after the first vaccination. received 3-dose intramuscular priming series (3-i.m.) vaccine adsorbed (AVA) (BioThrax) 0, 1, 6 months. responses modulated by administering range dilutions. Together with...

10.1128/cvi.00469-14 article EN Clinical and Vaccine Immunology 2014-09-03

• ZIKV IgM kits from InBios, NovaTec and Euroimmun were compared in 3 separate labs. InBios kit was most sensitive; Novatec specific. Concordance across the labs high for both + IgG kits. The NS1-based may be useful confirmation of infection a portion patients to reduce number PRNT's required.

10.1016/j.jviromet.2018.06.018 article EN cc-by Journal of Virological Methods 2018-06-30

The diagnosis of dengue disease, caused by the virus (DENV) (a flavivirus), often requires serologic testing during acute and early convalescent phases disease. Some symptoms DENV infection, such as nonspecific fever, are similar to those infection with SARS-CoV-2, that causes COVID-19. In studies few COVID-19 cases, positive immunoglobulin M (IgM) results were reported various tests, indicating possible cross-reactivity in these tests for SARS-CoV-2 infections (1,2). antibodies can...

10.15585/mmwr.mm7110a3 article EN MMWR Morbidity and Mortality Weekly Report 2022-03-10

Although COVID-19 vaccine efficacy (VE) studies have estimated antibody concentrations that correlate with protection from COVID-19, how these estimates compare to those generated in response SARS-CoV-2 infection is unclear. We assessed quantitative neutralizing and binding using standardized assays on serum specimens collected COVID-19-unvaccinated persons detectable antibodies.

10.1128/spectrum.01247-22 article EN cc-by Microbiology Spectrum 2022-07-20

Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) is a novel human that was identified in 2019. SARS-CoV-2 infection results an acute, severe disease called 2019 (COVID-19). The emergence and rapid spread of has led to global public health crisis, which continues affect populations across the globe. Real time reverse transcription polymerase chain reaction (rRT-PCR) reference standard test for COVID-19 diagnosis. Serological tests are valuable tools serosurveillance...

10.1099/acmi.0.000463.v4 article EN cc-by-nc Access Microbiology 2024-02-01
Coming Soon ...